Patients with late-onset Alzheimer’s may show some long-term benefit, but none for early-onset.
In a report of the phase II ADvance clinical trial, Johns Hopkins researchers report that people diagnosed under age 65—those with early-onset Alzheimer’s disease—didn’t benefit from deep brain stimulation. Their findings appeared in the July issue of the Journal of Alzheimer’s Disease.
Drs Okun and Foote are co-authors on this paper. You can read the full article here.